Back to search

University of British Columbia

The development of an anti-thrombotic and anti-inflammatory coating for medical devices

Abstract

dc:description

Blood-contacting biomaterials are commonly and increasingly used in medical devices including for example, vascular grafts, coronary stents, prosthetic heart valves, and extracorporeal pumps. A major and persistent problem of exposing blood to a foreign biomaterial surface is that a thromboinflammatory response is triggered that may cause device failure and/or systemic inflammation and clotting. Several biomaterial coatings, particularly heparin, are currently used to prevent thromboinflammation, but these do not reliably work. The goal of my thesis was to develop a novel blood compatible surface coating that simultaneously prevents thrombosis and inflammation by immobilizing anticoagulant and anti-inflammatory molecules in a more functional manner, onto a universal surface coating. This thesis is divided into two parts. In the first part, I chemically modified unfractionated heparin, a potent anticoagulant, on one end such that it could be conjugated to the universal antifouling surface coating in an orientation that optimally and uniformly exposed its anticoagulant antithrombin binding site. The functional properties of this heparin coating were tested under static and dynamic conditions, and these verified that this novel heparin coating was protective against thrombosis. In the second part, I modified the cDNA encoding the naturally occurring anti-inflammatory lectin-like domain of thrombomodulin (TM-LLD), such that it could be expressed by cultured mammalian cells, purified by affinity chromatography, and then conjugated to the antifouling surface coating in an accessible orientation. The purified soluble TM-LLD exhibited anti-inflammatory properties, in that it dampened leukocyte adhesion and complement activation. However, its activity when bound to the surface coating has yet to be confirmed. While further studies are required to optimize the function and to test the stability of these immobilized molecules, this thesis has provided proof-of-concept that the potent anti-coagulant, heparin, and the anti-inflammatory TM-LLD, can be chemically modified for conjugation to the antifouling surface in an orientation to optimize function. Future work will include experiments to upscale production of the modified proteins, to verify their functions and stability under different conditions, and finally, to apply combinatorial approaches to simultaneously bind the molecules to the coating to yield a truly biocompatible, biomaterial surface that prevents both thrombosis and inflammation.

Degree

thesis:*
Name thesis:degree_name
Master of Science - MSc
Level thesis:degree_level
master's
Discipline thesis:degree_discipline
Pathology and Laboratory Medicine
Grantor dc:publisher
University of British Columbia
Year dc:date
2023

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Gonzalez, Jessie Kevin
Contributors dc:contributor
  • Conway, Edward M.
  • Kizhakkedathu, Jayachandran N.

Rights

dc:rights
Statement dc:rights
  • Attribution-NonCommercial-NoDerivatives 4.0 International
Language dc:language
eng

Identifiers

dc:identifier.*
Handle dc:identifier
http://hdl.handle.net/2429/86722

Chain of custody

source
Harvested from
University of British Columbia
Base URL
circle.library.ubc.ca/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Gonzalez, Jessie Kevin. The development of an anti-thrombotic and anti-inflammatory coating for medical devices. master's thesis, University of British Columbia, 2023. http://hdl.handle.net/2429/86722